You can select one or bundle both products to complete the ultimate eye care experience.
Complete our secure medical intake form online and one of our medical providers will review.
Provide a current photo of your full face and an image of your valid, state-issued ID or Complete Video Consultation*
*Telemedicine law varies from state to state
Upneeq is a once-daily prescription eye drop for acquired ptosis (low-lying lids) that lifts your upper eyelids.
Rhoncus in aliquet quisque torquent mollis per si metus donec himenaeos elit.
Rhoncus in aliquet quisque torquent mollis per si metus donec himenaeos elit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
In 2001, Allergan developed a medicated eye drop called bimatoprost to treat glaucoma. By a stroke of serendipity, many of the patients noticed something happening to their eyelashes. Their eyelashes grew longer, fuller, and darker while on the medication. This unexpected side effect prompted Allergan to study bimatoprost for the use in eyelash hypotrichosis, which is the medical term for an inadequate amount of hair.
The study produced remarkable results. At week 16, patients had an average of 1.4 mm growth in length (25 percent increase) and a 106 percent increase in fullness and thickness. The results of the study resulted in Latisse® become the first and only FDA-approved treatment to lengthen, darken, and thicken eyelashes for people with insufficient lashes.
Upneeq is a once-daily eye drop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes.